A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

External-beam radiation therapy for head and neck cancers delivers radiation from a machine outside the body to destroy a cancer’s DNA, denying it instructions to grow and multiply. A radiation ...

More Americans are beating cancer than ever, yet many still grapple with treatment's long shadow—especially on their mental ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...

Cancer is a debilitating illness that remains a persistent threat to humanity and is one of the leading causes of death ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

There is a positive association between exposure to at least 1 head/neck CT scan and the risk for pediatric brain tumors.